液体活检技术在食管鳞状细胞癌中的研究进展

国际肿瘤学杂志››2024,Vol. 51››Issue (2): 105-108.doi:10.3760/cma.j.cn371439-20230621-00015

液体活检技术在食管鳞状细胞癌中的研究进展

刘博翰, 黄俊星()

南京医科大学附属泰州人民医院肿瘤科，泰州 225300
大连医科大学临床医学系，大连 116000

收稿日期:2023-06-21修回日期:2023-11-06出版日期:2024-02-08发布日期:2024-04-03
通讯作者:黄俊星，Email： hjxtz@sina.cn
基金资助:
江苏省卫生健康委科研课题(BJ20012);泰州市科学技术局2020年社会发展指令性计划(TS202001);江苏省医学创新团队项目(CXTDA2017042)

Research progress of liquid biopsy technology in esophageal squamous cell carcinoma

Liu Bohan, Huang Junxing()

Department of Oncology，Affiliated Taizhou People's Hospital of Nanjing Medical University，Taizhou 225300，China
Department of Clinical Medicine，Dalian Medical University，Dalian 116000，China

Received:2023-06-21Revised:2023-11-06Online:2024-02-08Published:2024-04-03
Contact:Huang Junxing，Email： hjxtz@sina.cn
Supported by:
Jiangsu Provincial Health Commission Research Project(BJ20012);Taizhou Science and Technology Bureau 2020 Social Development Mandatory Plan Project(TS202001);Medical Innovation Team Project of Jiangsu Province of China(CXTDA2017042)

摘要/Abstract

摘要：

近年来，随着生物技术的不断发展，液体活检技术在肿瘤领域的研究逐渐成为研究的热点，其作为一种非侵入性的诊断方法，相较于传统手段具有很大的优势。液体活检技术显示出精准、方便、无创、安全等特点，在食管鳞状细胞癌的早期诊断、治疗及预后评估方面具有越来越重要的临床意义。

关键词:食道鳞癌,肿瘤细胞,循环,外泌体,循环肿瘤DNA,循环肿瘤RNA

Abstract:

In recent years，with the continuous development of biotechnology，liquid biopsy techno-logy has gradually become a research hotspot in the field of tumor research. As a non-invasive diagnostic method，liquid biopsy has great advantages compared with traditional methods. The liquid biopsy technology is precise，convenient，non-invasive and safe，and has an increasingly important clinical significance in the early diagnosis，treatment and prognosis assessment of esophageal squamous cell carcinoma.

Key words:Esophageal squamous cell carcinoma,Neoplastic cells,circulating,Exosomes,Circula-ting tumor DNA,Circulating tumor RNA

刘博翰, 黄俊星. 液体活检技术在食管鳞状细胞癌中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(2): 105-108.

Liu Bohan, Huang Junxing. Research progress of liquid biopsy technology in esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(2): 105-108.

参考文献30

[1]	He Z, Ke Y. Precision screening for esophageal squamous cell carcinoma in China[J].Chin J Cancer Res,2020,32(6): 673-682. DOI:10.21147/j.issn.1000-9604.2020.06.01.
[2]	Shah MA, Kennedy EB, Catenacci DV, et al. Treatment of locally advanced esophageal carcinoma: ASCO guideline[J].J Clin Oncol,2020,38(23): 2677-2694. DOI:10.1200/JCO.20.00866. pmid:32568633
[3]	Wu C, Zhang J, Li H, et al. The potential of liquid biopsies in gastrointestinal cancer[J].Clin Biochem,2020,84: 1-12. DOI:10.1016/j.clinbiochem.2020.06.007. pmid:32540214
[4]	Shi Y, Ge X, Ju M, et al. Circulating tumor cells in esophageal squamous cell carcinoma-mini review[J].Cancer Manag Res,2021,13: 8355-8365. DOI:10.2147/CMAR.S337489.
[5]	Choi MK, Kim GH, I H, et al. Circulating tumor cells detected using fluid-assisted separation technique in esophageal squamous cell carcinoma[J].J Gastroenterol Hepatol,2019,34(3): 552-560. DOI:10.1111/jgh.14543.
[6]	Han L, Li YJ, Zhang WD, et al. Clinical significance of tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma[J].Medicine (Baltimore),2019,98(6): e13921. DOI:10.1097/MD.0000000000013921.
[7]	Zhao Y, Han L, Zhang W, et al. Preoperative chemotherapy compared with postoperative adjuvant chemotherapy for squamous cell carcinoma of the thoracic oesophagus with the detection of circula-ting tumour cells randomized controlled trial[J].Int J Surg,2020,73: 1-8. DOI:10.1016/j.ijsu.2019.11.005.
[8]	Lee HJ, Kim GH, Park SJ, et al. Clinical significance of TWIST-positive circulating tumor cells in patients with esophageal squamous cell carcinoma[J].Gut Liver,2021,15(4): 553-561. DOI:10.5009/gnl20194. pmid:33293482
[9]	Kok VC, Yu CC. Cancer-derived exosomes: their role in cancer biology and biomarker development[J].Int J Nanomedicine,2020,15: 8019-8036. DOI:10.2147/IJN.S272378.
[10]	Luo A, Zhou X, Shi X, et al. Exosome-derived miR-339-5p me-diates radiosensitivity by targeting Cdc25A in locally advanced esophageal squamous cell carcinoma[J].Oncogene,2019,38(25): 4990-5006. DOI:10.1038/s41388-019-0771-0.
[11]	Qiu ML, Li X, Lin JB, et al. Serum exosomal miR-182 upregulation predicts unfavorable prognosis of esophageal squamous cell carcinoma[J].Eur Rev Med Pharmacol Sci,2020,24(10): 5412-5418. DOI:10.26355/eurrev_202005_21325.
[12]	Li P, Liu X, Xing W, et al. Exosome-derived miR-200a promotes esophageal cancer cell proliferation and migration via the media-ting Keap1 expression[J].Mol Cell Biochem,2022,477(4): 1295-1308. DOI:10.1007/s11010-022-04353-z.
[13]	Liu Z, Huang Y, Han Z, et al. Exosome-mediated miR-25/miR-203 as a potential biomarker for esophageal squamous cell carcinoma: improving early diagnosis and revealing malignancy[J].Transl Cancer Res,2021,10(12): 5174-5182. DOI:10.21037/tcr-21-1123. pmid:35116367
[14]	Han GL, Wang J, Guo K, et al. MiRNA-574-5p downregulates ZNF70 and influences the progression of human esophageal squamous cell carcinoma through reactive oxygen species generation and MAPK pathway activation[J].Anticancer Drugs,2020,31(3): 282-291. DOI:10.1097/CAD.0000000000000833. pmid:32053575
[15]	Li K, Lin Y, Luo Y, et al. A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study[J].Mol Cancer,2022,21(1): 21. DOI:10.1186/s12943-022-01499-8. pmid:35042519
[16]	Lin Y, Dong H, Deng W, et al. Evaluation of salivary exosomal chimeric GOLM1-NAA35 RNA as a potential biomarker in esophageal carcinoma[J].Clin Cancer Res,2019,25(10): 3035-3045. DOI:10.1158/1078-0432.CCR-18-3169.
[17]	Yan L, Dong X, Gao J, et al. A novel rapid quantitative method reveals stathmin-1 as a promising marker for esophageal squamous cell carcinoma[J].Cancer Med,2018,7(5): 1802-1813. DOI:10.1002/cam4.1449.
[18]	Chen M, Zhao H. Next-generation sequencing in liquid biopsy: cancer screening and early detection[J].Hum Genomics,2019,13(1): 34. DOI:10.1186/s40246-019-0220-8. pmid:31370908
[19]	Pessoa LS, Heringer M, Ferrer VP. ctDNA as a cancer biomarker: a broad overview[J].Crit Rev Oncol Hematol,2020,155: 103109. DOI:10.1016/j.critrevonc.2020.103109.
[20]	Liu T, Yao Q, Jin H. Plasma circulating tumor DNA sequencing predicts minimal residual disease in resectable esophageal squamous cell carcinoma[J].Front Oncol,2021,11: 616209. DOI:10.3389/fonc.2021.616209.
[21]	Morimoto Y, Matsuda S, Kawakubo H, et al. Tumor burden monitoring with circulating tumor DNA during treatment in patients with esophageal squamous cell carcinoma[J].Ann Surg Oncol,2023,30(6): 3747-3756. DOI:10.1245/s10434-023-13194-z. pmid:36788188
[22]	Wang X, Yu N, Cheng G, et al. Prognostic value of circulating tumour DNA during post-radiotherapy surveillance in locally advanced esophageal squamous cell carcinoma[J].Clin Transl Med,2022,12(11): e1116. DOI:10.1002/ctm2.1116. pmid:36437506
[23]	Jia R, Zhao CH, Li PS, et al. Post-radiation circulating tumor DNA as a prognostic factor in locally advanced esophageal squamous cell carcinoma[J].Oncol Lett,2021,21(1): 68. DOI:10.3892/ol.2020.12329. pmid:33365079
[24]	Feng Q, Zhang H, Yao D, et al. Emerging role of non-coding RNAs in esophageal squamous cell carcinoma[J].Int J Mol Sci,2019,21(1): 258. DOI:10.3390/ijms21010258.
[25]	De Rubis G, Rajeev Krishnan S, Bebawy M. Liquid biopsies in cancer diagnosis, monitoring, and prognosis[J].Trends Pharmacol Sci,2019,40(3): 172-186. DOI:10.1016/j.tips.2019.01.006. pmid:30736982
[26]	Si W, Shen J, Zheng H, et al. The role and mechanisms of action of microRNAs in cancer drug resistance[J].Clin Epigenetics,2019,11(1): 25. DOI:10.1186/s13148-018-0587-8. pmid:30744689
[27]	Han L, Cui D, Li B, et al. MicroRNA-338-5p reverses chemoresistance and inhibits invasion of esophageal squamous cell carcinoma cells by targeting Id-1[J].Cancer Sci,2019,110(12): 3677-3688. DOI:10.1111/cas.14220.
[28]	Szilágyi M, Pös O, Márton É, et al. Circulating cell-free nucleic acids: main characteristics and clinical application[J].Int J Mol Sci,2020,21(18): 6827. DOI:10.3390/ijms21186827.
[29]	Sharma U, Barwal TS, Khandelwal A, et al. Circulating long non-coding RNAs LINC00324 and LOC100507053 as potential liquid biopsy markers for esophageal squamous cell carcinoma: a pilot study[J].Front Oncol,2022,12: 823953. DOI:10.3389/fonc.2022.823953.
[30]	Luo D, Huang Z, Lv H, et al. Up-regulation of microRNA-21 indicates poor prognosis and promotes cell proliferation in esophageal squamous cell carcinoma via upregulation of lncRNA SNHG1[J].Cancer Manag Res,2020,12: 1-14. DOI:10.2147/CMAR.S221731. pmid:32021418